A rapid-flow cytofluorometric susceptibility test for in vitro amphotericin B testing of yeasts was evaluated and compared to the National Committee for Clinical Laboratory Standards (NCCLS) M27-T reference broth macrodilution method. The flow cytofluorometric method is based on the detection of decreased green fluorescence intensity of cells stained with DiOC 5 (3), a membrane potential-sensitive cationic dye, after drug treatment. Testing was performed on 134 clinical isolates (Candida spp. and Torulopsis glabrata). From the dose-response curve obtained for each isolate, three endpoints were calculated by computer analysis (the concentrations at which the fluorescence intensity was reduced by 50, 80, and 90%, i.e., 50% inhibitory concentration [IC 50 ], IC 80 , and IC 90 , respectively). A regression analysis correlating these endpoints with the M27-T MICs showed that the best agreement was obtained with IC 80 . The flow cytofluorometric method showed good reproducibility with control strains. These initial results suggest that the flow cytofluorometric method is a valid alternative to the NCCLS reference method.
The increasing incidence of opportunistic fungal infections and the development of new, potent antifungal drugs have greatly enhanced the interest in methods for in vitro antifungal susceptibility testing. The standardized methodology recently recommended by the National Committee for Clinical Laboratory Standards (NCCLS), M27-T (4), is a significant step in the development of a reference testing method. Nevertheless, this macrodilution technique is cumbersome and labor intensive. Moreover, its reliability in identifying amphotericin B-resistant isolates has been questioned (10, 11) . Several alternative methods are under evaluation (1) . As these methods are still based on the presence or absence of visually discernible fungal growth, they are also time consuming.
Flow cytometry is widely used in diagnostic and research laboratories. By using specific fluorochromes, this method allows for rapid, multiparametric analysis of a large number of cells in liquid suspensions. In addition, flow cytometry makes it possible to discriminate between otherwise indistinguishable microbial subpopulations. It has naturally found applications in microorganism viability testing; flow cytofluorometric susceptibility tests (FCST) were recently extended from bacteria to clinically important yeasts (2, 9) . In 1995 Ordonez and Wehman (6) demonstrated that the cationic dye DiOC 5 (3), used to monitor early membrane depolarization caused by amphotericin B, served to discriminate between resistant and susceptible reference Candida strains.
The objective of the present study was to further evaluate this technique with a panel of Candida spp. and Torulopsis glabrata clinical isolates. For each isolate, the dose-response curve and four susceptibility endpoints were calculated by computer analysis. Results were compared with the MICs of the NCCLS broth macrodilution M27-T method.
MATERIALS AND METHODS

Test organisms.
A total of 134 clinical isolates were tested. The species represented were Candida albicans (30 isolates), Candida lusitaniae (34 isolates), Candida tropicalis (20 isolates), Candida krusei (19 isolates), Candida parapsilosis (9 isolates), and T. glabrata (22 isolates). They were identified by standard methods (12) and the API 32C system (bioMérieux, Marcy l'Etoile, France). Isolates were maintained on Sabouraud agar (bioMérieux) slants and stored at 4°C. Most of the isolates were from patients in intensive care units. They were recovered from upper respiratory tract (68 isolates), mouth (13 isolates), stool (12 isolates), urine (17 isolates), skin (12 isolates), vagina (10 isolates), and blood (1 isolate) cultures.
Reference strains. The reference strains C. albicans ATCC 90029 (MIC ϭ 0.25 to 1 g/ml) and C. tropicalis IP 1275-81 (MIC Ն 2 g/ml) were included in each series of experiments as the internal controls.
Antifungal agent. Amphotericin B (Sigma, St. Louis, Mo.) was dissolved in dimethyl sulfoxide (reagent grade; Sigma) at a starting concentration of 12,800 g/ml. The stock solution was stored frozen at Ϫ70°C until used.
Standard antifungal susceptibility testing. Broth macrodilution susceptibility testing was performed as described in the NCCLS M27-T protocol by using RPMI 1640 medium (Sigma) (4). The incubation period was 48 h at 35°C. The MIC was defined according to the NCCLS criteria (the MIC endpoint was read as the lowest amphotericin B concentration preventing discernible growth). When testing C. lusitaniae isolates, antibiotic medium 3 broth (bioMérieux) supplemented with glucose (20 g/liter) was used concurrently (11) .
FCST conditions. The conditions for the FCST were those of Ordonez and Wehman (6) with slight modifications. Briefly, the assay medium was RPMI 1640 with L-glutamine (Sigma) buffered to pH 7.0 with 0.165 M MOPS (morpholinepropanesulfonic acid) buffer instead of Sabouraud glucose broth. Drug dilutions were prepared to 10 times the strength of the final concentration with medium as the diluent (e.g., 0.3 to 160 g/ml). The yeasts were grown on Sabouraud glucose agar for 24 h at 35°C. Stock inoculum suspensions were made in sterile 0.85% saline and spectrophotometrically adjusted at 530 nm to a final transmission from 70 to 75% (7). The viable count of each working inoculum was confirmed by spread plating it in serial dilutions in sterile 0.85% saline on Sabouraud glucose agar. The adjusted yeast suspensions were diluted 1:10 with the medium to achieve a final concentration of 5 ϫ 10 5 to 8 ϫ 10 5 CFU/ml. Except for the growth control, the final inoculum was added in 0.9-ml aliquots to glass tubes containing 0.1 ml of drug dilutions. Final concentrations of amphotericin B ranged from 0.03 to 16 g/ml. Incubation was performed at 27°C for 30 min. DiOC 5 (3) (Molecular Probes, Eugene, Oreg.) was then added to all tubes at a final concentration of 0.5 M. Flow cytofluorometric analysis was initiated 5 min after adding the dye to the first tube.
Flow cytometry. Samples were run on a FACSort cytometer (Becton Dickinson, Sunnyvale, Calif.) with a 15-mW, 488-nm argon ion laser and a Consort 32 workstation combined with Lysis II software. Instrumental parameters were forward light scatter (FSC, Log), sideward light scatter (SSC, Log, 304 PMT voltage, 488/10 filter), and green fluorescence (FL1, Log, 443 PMT voltage, 530/30 filter). An untreated control of each isolate was sampled first. A gate that excluded cell clusters and debris was adjusted from a cytogram obtained by plotting forward light scatter against sideward light scatter. Five thousand cells per sample were analyzed, and data were recorded as histograms of fluorescence. The geometric mean of fluorescence for the defined population was calculated with the Becton Dickinson software.
Study design and statistical analysis. Dose-response relationships were determined with a nonlinear model: F ϭ ab/(b ϩ C), where F is the fluorescence mean, a and b are coefficients calculated by nonlinear regression analysis, and C is the amphotericin B concentration (g/ml). For each isolate, three parameters corresponding to three possible endpoint definitions were calculated from this relationship. They were drug concentrations which produced a 50, 80, and 90% decrease in fluorescence mean compared to the fluorescence mean of the drugfree control (50% inhibitory concentration [IC 50 ] ϭ b, IC 80 ϭ 4b, and IC 90 ϭ 9b, respectively). These parameters were directly correlated with the MIC. For each linear model, analysis of variance was performed. All calculations were done with the Table Curve 2D (version 3.0) software (Jandel Scientific). For assessment of reproducibility, each of the reference strains was tested in duplicate; this was done seven times throughout the course of the study.
RESULTS
Cell membrane depolarization in amphotericin B-treated cells was evidenced by decreased DiOC 5 (3) uptake, resulting in a dose-dependent decrease in cellular fluorescence intensity. A dose-response curve was modelized for each strain. As an example, Fig. 1 were derived by computer analysis of the raw data. The probability value of the nonlinear model for all samples was P Ͻ 0.001. Susceptibility testing according to the NCCLS proposed method was performed concurrently with the same stock inoculum suspensions. Table 1 summarizes the NCCLS MICs and flow cytofluorometric endpoints thus obtained. For each strain, we did a regression analysis correlating each flow cytofluorometric parameter with the NCCLS MIC ( Table 2 ). The best correlation was between NCCLS MICs and IC 80 s (Fig.  2) . A strain-by-strain analysis of the data shows that major discrepancies between MICs and IC 80 s were often species specific. An IC 80 significantly higher than the MIC was noted with some T. glabrata strains (data not shown). The reproducibility of the method was evaluated by testing the two reference strains in duplicate seven times each; IC 80 endpoints were determined, and the coefficients of variation were calculated (Table 3) .
DISCUSSION
The in vitro antifungal susceptibility test is seriously limited by the time required to get results, even by using alternative approaches of the proposed NCCLS reference method. The present study has investigated a flow cytofluorometric test for amphotericin B susceptibility testing of yeasts. Our results confirm and extend the observations of Ordonez and Wehman (6), who reported that the dye DiOC 5 (3) could be used to rapidly evaluate the susceptibility of Candida sp. isolates to amphotericin B. Our study was conducted with 134 clinical isolates which were selected to represent the most common pathogenic yeast species and to include a wide range of susceptibilities. Synthetic culture medium RPMI 1640, adopted by the NCCLS, was used in the FCST without affecting the performance of the test. Note that our evaluation of the agreement differed from that in most studies of yeast susceptibility test methods. Generally, differences between endpoints are analyzed in terms of the numbers of twofold drug dilutions. In our study, the susceptibility of each strain was characterized by four parameters, and the FCST method was compared with the NCCLS proposed standard through a regression analysis of the data. We therefore calculated ICs from an arbitrary mathematical model and compared them with the discontinuous NCCLS MICs. The best correlation was obtained with the IC 80 endpoint (r ϭ 0.4419, n ϭ 134), and this criterion is proposed as optimal for amphotericin B susceptibility determination by this flow cytometric method. The discrepancies found with some T. glabrata isolates could be explained by the reduced uptake of fluorochrome observed, which decreased the performance of the test. According to the method of Rex et al. (11) , we used antibiotic medium 3 broth to test C. lusitaniae isolates by the NCCLS broth macrodilution method. All the isolates were inhibited by less than 1 g of amphotericin B per ml. The FCST provided a broad range of endpoints which was consistent with the NCCLS M27-T MIC range. Concerning the reproducibility study, IC 80 distribution was very tight. The rank order of susceptibilities was in agreement with the reference rank order, and a clear-cut separation between the susceptible C. albicans ATCC 90029 and the resistant C. tropicalis IP 1275-81 was observed.
Few publications have dealt with flow cytometry in antifungal susceptibility testing (9) . Those which focus on the susceptibility to amphotericin B (3, 5, 8) used propidium iodide or rose bengal as fluorochromes, and 3 to 9 h of incubation was required. From our data, it appears that DiOC 5 (3) FCST is rapid (data are generated within 1 h), sensitive, and accurate. Additional studies including putative amphotericin B-resistant isolates should further validate this method.
In conclusion, this method is a valuable alternative to conventional amphotericin B testing methods. It offers the advantage of a rapid analysis. This could be especially useful for effectively monitoring therapy in the rare but often dramatic cases in which resistance to amphotericin B is suspected. 
